MedTrace Logo

Brief Intervention Study for Quitting Smoking

NCT01589211 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 347

Last updated 2022-09-06

No results posted yet for this study

Summary

To investigate the effectiveness of a smoking cessation intervention of two sessions (120 min at a time) in a group setting on the basis of Motivational Interviewing (MI) and important elements of Cognitive Behavioural Therapy (CBT). According to national and international guidelines patients are advised to quit and pharmacologically supported with one of the established first line smoking cessation treatments.

Conditions

  • Smoking
  • Tobacco Use Cessation
  • Smoking Cessation

Interventions

BEHAVIORAL

Brief advice

Brief advice of about 10 min accompanied by self-help material

BEHAVIORAL

Compact cessation course

Compact cessation course on the basis of Motivational Interviewing (MI) and Cognitive Behavioural Therapy (CBT). Group setting. 2 x 120 min.

BEHAVIORAL

Standard cessation course

Cessation course over 6 dates. Group setting.

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Alexander Rupp, Dr. · Heidelberg University

  • Michael Kreuter, PD Dr. · Heidelberg University

  • Felix JF Herth, Prof. · Heidelberg University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-16
Primary Completion
2013-04-11
Completion
2013-04-11

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01589211 on ClinicalTrials.gov